Locations:
Search
Making sense of the fast-moving treatment landscape
Explaining common misconceptions about chimeric antigen receptor therapy
Study examines modifiable determinants of health disparities
Prediction and bioinformatic data could prove valuable for therapeutic interventions targeting this malignancy
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Findings from large database important to inform clinical practice
What’s coming up at ASH and beyond
Key research findings to watch
Gene editing technology offers promise for treating multiple myeloma and other hematologic malignancies, as well as solid tumors
Study of 401,576 patients reveals differences in cancer burdens as well as overall survival
Patients with a prior history of VTA are at an increased risk of subsequent incidents, despite treatment with therapeutic anticoagulation
Advertisement
Advertisement